Dean Y Li Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 11 minutes ago
Dean Y Li has an estimated net worth of at least $17.6 million*, as of today. They own 94,431 shares of MRK stock. They have sold 93,789 shares of MRK stock since 2021, for an estimated $3.6 million.
Dean Y Li $MRK SEC Form 4 Insider Trading
Dean Y Li has filed a total of 2 insider trades in $MRK since 2021. Their most recent trade was a sale of 15,087 shares, made on Feb 04, 2026. Their largest trade was a sale of 15,087 shares, made on Feb 04, 2026. We estimate that they now own 94,431 shares of $MRK, worth an estimated $14.0 million.
Insider Trading at $MRK
There have been a total of 125 insider trades reported at $MRK since 2021, with 18,241 shares purchased and 5.7 million shares sold. The most active insider traders in $MRK stock have been Kenneth C Frazier, Richard R. Deluca, and Steven Mizell. The most recent trade was a sale of 10,000 shares reported by Chirfi Guindo (EVP, Access, Policy & Comms), made on Aug 13, 2026.
History of Insider Stock Trades by Dean Y Li
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
MRK
|
Sale | 15,087 | Feb 04, 2026 | Feb. 6, 2026, 5:12 p.m. |
|
MRK
|
Sale | 14,702 | Feb 09, 2024 | Feb. 12, 2024, 5:03 p.m. |
RXRX
|
Sale | 28,038 | Jan 09, 2024 | Jan. 11, 2024, 7:51 p.m. |
|
RXRX
|
Sale | 962 | Jan 09, 2024 | Jan. 11, 2024, 7:51 p.m. |
|
RXRX
|
Sale | 1,000 | Dec 07, 2021 | Dec. 9, 2021, 10:21 p.m. |
|
RXRX
|
Sale | 14,900 | Dec 07, 2021 | Dec. 9, 2021, 10:21 p.m. |
|
RXRX
|
Sale | 5,626 | Nov 17, 2021 | Nov. 19, 2021, 6:40 p.m. |
|
RXRX
|
Sale | 13,474 | Nov 19, 2021 | Nov. 19, 2021, 6:40 p.m. |
$MRK Executives and Stock Owners with Insider Trades
-
Kenneth C Frazier, Executive Chair
-
Richard R. Deluca, EVP&Pres, Merck Animal Heallth
-
Steven Mizell, EVP, Chief HR Officer
-
Joseph Romanelli, President, Human Health Int?l
-
Sanat Chattopadhyay, Exe V-P & Pres. MMD
-
Jennifer Zachary, EVP, General Counsel
-
David Michael Williams, EVP,Chief Info&Digital Officer
-
Robert M Davis, Chairman, CEO & President
-
Johannes Jacobus Oosthuizen, President, U.S. Market
-
Chirfi Guindo, Chief Marketing Officer
-
David R. Maraldo, EVP & Pres. MMD
-
Rita A Karachun, Sr. VP Fince-Global Controller
-
Robert M Davis, CEO & President
-
Caroline Litchfield, EVP & CFO
-
Dean Y Li, Executive VP & President, MRL
-
Dalton E. Iii Smart, SVP Fin. - Global Controller
-
Cristal N Downing, Chief Comm. & Public Afrs Ofcr
-
Chirfi Guindo, EVP, Access, Policy & Comms
-
Frank Clyburn, EVP & Pres ? Human Health
-
Julie L. Gerberding, EVP, Chief Patient Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.